Cargando…

Apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside reduces myocardial ischaemia/reperfusion injury in an experimental model via regulating the inflammation response

CONTEXT: Traditionally, Clematis tangutica Korsh. (Ranunculaceae) is used as a Tibetan herb for treating indigestion and blood stasis in China. Recently, a flavonoid glycoside, apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside (APG), was isolated from the whole plant of C. tangutica. OBJECTIVE: To i...

Descripción completa

Detalles Bibliográficos
Autores principales: Quan, Wei, Ma, Shanbo, Zhu, Yanrong, Shao, Qing, Hou, Jixing, Li, Xiaoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968710/
https://www.ncbi.nlm.nih.gov/pubmed/31887257
http://dx.doi.org/10.1080/13880209.2019.1701043
_version_ 1783489192221736960
author Quan, Wei
Ma, Shanbo
Zhu, Yanrong
Shao, Qing
Hou, Jixing
Li, Xiaoqiang
author_facet Quan, Wei
Ma, Shanbo
Zhu, Yanrong
Shao, Qing
Hou, Jixing
Li, Xiaoqiang
author_sort Quan, Wei
collection PubMed
description CONTEXT: Traditionally, Clematis tangutica Korsh. (Ranunculaceae) is used as a Tibetan herb for treating indigestion and blood stasis in China. Recently, a flavonoid glycoside, apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside (APG), was isolated from the whole plant of C. tangutica. OBJECTIVE: To investigate the cardioprotective effects of APG against myocardial ischaemia/reperfusion injury (MI/RI) and the possible mechanism. MATERIALS AND METHODS: Animals were subjected to 30 min/3 h MI/RI model. At the end of reperfusion, infarct size (IS), histopathology, serum levels CK-MB, LDH, TNF-α, IL-6 and MPO activities were detected. Phospho-IκB-α, ICAM-1 and NF-κB were assessed in vivo. Neonatal rat cardiomyocytes were pre-treated with or without APG, followed by stimulation with 8 h/2 h oxygen and glucose deprived/reoxygenation (OGD/R) model. Cell viability, LDH and cardiomyocyte apoptosis were assessed. The expression levels of phospho-IκB-α and NF-κB were measured in vitro. RESULTS: Treatment with APG significantly reduced the following indicators in vivo (p < 0.05): (1) the IS (16.2%); (2) morphology score (1.67); (3) myocardial injury enzymes: CK-MB (26.2 ng/mL) and LDH (688 U/L); (4) pro-inflammatory cytokines: TNF-α (31.5 pg/mL) and IL-6 (163.8 pg/mL); (5) MPO activity (2.75 U/mg); (6) expression levels of phospho-IκB-α (0.47), NF-κB (2.87) and ICAM-1 (10.2). Moreover, treatment with APG also remarkably (p < 0.05) attenuated the following indicators in vitro: (1) LDH level (206 U/L); (2) cardiomyocyte apoptosis; (3) phospho-IκB-α (1.37) and NF-κB (2.50). CONCLUSIONS: APG possesses protective effects against MI/RI injury in rats and OGD/R-induced injury in cardiomyocytes by suppressing translocation of NF-κB and reducing inflammatory response; consequently, APG is helpful for treatment of ischaemic heart disease.
format Online
Article
Text
id pubmed-6968710
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-69687102020-01-30 Apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside reduces myocardial ischaemia/reperfusion injury in an experimental model via regulating the inflammation response Quan, Wei Ma, Shanbo Zhu, Yanrong Shao, Qing Hou, Jixing Li, Xiaoqiang Pharm Biol Research Article CONTEXT: Traditionally, Clematis tangutica Korsh. (Ranunculaceae) is used as a Tibetan herb for treating indigestion and blood stasis in China. Recently, a flavonoid glycoside, apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside (APG), was isolated from the whole plant of C. tangutica. OBJECTIVE: To investigate the cardioprotective effects of APG against myocardial ischaemia/reperfusion injury (MI/RI) and the possible mechanism. MATERIALS AND METHODS: Animals were subjected to 30 min/3 h MI/RI model. At the end of reperfusion, infarct size (IS), histopathology, serum levels CK-MB, LDH, TNF-α, IL-6 and MPO activities were detected. Phospho-IκB-α, ICAM-1 and NF-κB were assessed in vivo. Neonatal rat cardiomyocytes were pre-treated with or without APG, followed by stimulation with 8 h/2 h oxygen and glucose deprived/reoxygenation (OGD/R) model. Cell viability, LDH and cardiomyocyte apoptosis were assessed. The expression levels of phospho-IκB-α and NF-κB were measured in vitro. RESULTS: Treatment with APG significantly reduced the following indicators in vivo (p < 0.05): (1) the IS (16.2%); (2) morphology score (1.67); (3) myocardial injury enzymes: CK-MB (26.2 ng/mL) and LDH (688 U/L); (4) pro-inflammatory cytokines: TNF-α (31.5 pg/mL) and IL-6 (163.8 pg/mL); (5) MPO activity (2.75 U/mg); (6) expression levels of phospho-IκB-α (0.47), NF-κB (2.87) and ICAM-1 (10.2). Moreover, treatment with APG also remarkably (p < 0.05) attenuated the following indicators in vitro: (1) LDH level (206 U/L); (2) cardiomyocyte apoptosis; (3) phospho-IκB-α (1.37) and NF-κB (2.50). CONCLUSIONS: APG possesses protective effects against MI/RI injury in rats and OGD/R-induced injury in cardiomyocytes by suppressing translocation of NF-κB and reducing inflammatory response; consequently, APG is helpful for treatment of ischaemic heart disease. Taylor & Francis 2019-12-30 /pmc/articles/PMC6968710/ /pubmed/31887257 http://dx.doi.org/10.1080/13880209.2019.1701043 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Quan, Wei
Ma, Shanbo
Zhu, Yanrong
Shao, Qing
Hou, Jixing
Li, Xiaoqiang
Apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside reduces myocardial ischaemia/reperfusion injury in an experimental model via regulating the inflammation response
title Apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside reduces myocardial ischaemia/reperfusion injury in an experimental model via regulating the inflammation response
title_full Apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside reduces myocardial ischaemia/reperfusion injury in an experimental model via regulating the inflammation response
title_fullStr Apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside reduces myocardial ischaemia/reperfusion injury in an experimental model via regulating the inflammation response
title_full_unstemmed Apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside reduces myocardial ischaemia/reperfusion injury in an experimental model via regulating the inflammation response
title_short Apigenin-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside reduces myocardial ischaemia/reperfusion injury in an experimental model via regulating the inflammation response
title_sort apigenin-7-o-β-d-(6″-p-coumaroyl)-glucopyranoside reduces myocardial ischaemia/reperfusion injury in an experimental model via regulating the inflammation response
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968710/
https://www.ncbi.nlm.nih.gov/pubmed/31887257
http://dx.doi.org/10.1080/13880209.2019.1701043
work_keys_str_mv AT quanwei apigenin7obd6pcoumaroylglucopyranosidereducesmyocardialischaemiareperfusioninjuryinanexperimentalmodelviaregulatingtheinflammationresponse
AT mashanbo apigenin7obd6pcoumaroylglucopyranosidereducesmyocardialischaemiareperfusioninjuryinanexperimentalmodelviaregulatingtheinflammationresponse
AT zhuyanrong apigenin7obd6pcoumaroylglucopyranosidereducesmyocardialischaemiareperfusioninjuryinanexperimentalmodelviaregulatingtheinflammationresponse
AT shaoqing apigenin7obd6pcoumaroylglucopyranosidereducesmyocardialischaemiareperfusioninjuryinanexperimentalmodelviaregulatingtheinflammationresponse
AT houjixing apigenin7obd6pcoumaroylglucopyranosidereducesmyocardialischaemiareperfusioninjuryinanexperimentalmodelviaregulatingtheinflammationresponse
AT lixiaoqiang apigenin7obd6pcoumaroylglucopyranosidereducesmyocardialischaemiareperfusioninjuryinanexperimentalmodelviaregulatingtheinflammationresponse